Iran, a country in the Middle East and North Africa (MENA) region, has been actively
involved in the fight against HIV/AIDS over the past three decades. The unique features of …

Human immunodeficiency virus (HIV) in the Middle East and North Africa (MENA) region is
severely understudied despite the region's increase in new HIV infections since 2010. A key …

Backgrounds and aims Iran has 2.1 and 1.8% of its 15–64‐year‐old population living with
illicit substance and opioid use disorders, respectively. To address these problems, Iran has …

Injection drug use has been the leading route of HIV transmission in Iran. We assessed HIV
prevalence, risk behaviors, and uptake of prevention services among people who inject …

Background There has been a marked growth in methadone maintenance treatment (MMT)
in Iran in the past two decades with positive health outcomes. We conducted a systematic …

Abstract Background Supervised injection facilities (SIFs) have not yet been integrated into
Iran's harm reduction programs. This study aimed to report the extent to which people who …

Background Prevalence of hepatitis C virus (HCV) infection among people who inject drugs
(PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm …

Background: There is a high prevalence of substance use disorders, especially among men,
in Iran and is associated with a high burden on families. We aimed to systematically review …

Iran has the highest rate of nonmedical opium use in the world and, for four decades, has
been dealing with the negative impacts of the United States' and the United Nations' …

Background People who use drugs (PWUD) are considered as one of the main at-risk
populations for Hepatitis B virus (HBV) infection. We conducted a systematic review on the …